Cosmic EclipseCosmic Eclipse🃏All Clefairy cards
Ask about Clefairy
Clefairy #144 Pokémon card from Cosmic Eclipse

Clefairy 144/236

Cosmic Eclipse

Find this card on eBay

Affiliate link · we may earn commission

Clefairy #144 from Cosmic Eclipse currently trades at $1.62 raw, with PSA 10 copies reaching $37.76 — a 23.3x grade premium.
Current Prices (USD)
Ungraded
$1.62
PSA 7
$14.00
PSA 8
$14.00
PSA 9
$23.22
PSA 10
$37.76
ACE 10
BGS 10 Black
$245.00
CGC 10 Pristine
$41.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Clefairy 144/236 from Cosmic Eclipse has a current raw market value of $1.62.

Current raw value
$1.62
PSA 9 value
$23.22
PSA 10 value
$37.76
PSA 10 premium vs raw
23.3× raw
View all cards from Cosmic Eclipse
Collector Intel
23.3x
Raw → PSA 10
High-risk grade
14.3x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 23x the raw price. The expected value accounts for the realistic probability.
$2
Buy Raw
~$25
Grading Fee
PSA Standard
$38
PSA 10 Value
+$11
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$2314.3x raw
PSA 10$3823.3x raw

Frequently asked questions

How much is Clefairy #144 from Cosmic Eclipse worth?+
Clefairy #144 from Cosmic Eclipse is currently worth Raw: $1.62, PSA 9: $23.22, PSA 10: $37.76 based on recent sold listings. Prices update daily from real eBay sales.
Is Clefairy #144 worth grading?+
The PSA 10 price of $37.76 is 23.3× the raw price of $1.62. After a ~$25 grading fee, a PSA 10 result would net approximately $36.14 — assuming the card grades a 10.
Where do PokePrices Clefairy #144 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.